Trial Details
AuthorisedBasic Information
| Clinical ID | c5131 |
|---|---|
| Identifier | EUCTR2009-010921-38-NL |
| Trial Title | Chemopreventive effects of 5-ASA and UDCA in Ulcerative Colitis:.A Double-blind, Randomized Placebo-controlled Pilot Study. - CRC chemoprevention in UC |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | Ulcerative Colitis and the risk of developing colorectal cancer. MedDRA version: 13.1.Level: PT.Classification code 10021972.Term: Inflammatory bowel disease.System Organ Class: 10017947 - Gastrointestinal disorders_x00 |
| Interventions | Trade Name: SalofalkPharmaceutical Form: GranulesINN or Proposed INN: mesalazineCAS Number: 89-57-6Concentration unit: mg/kg milligram(s)/kilogramConcentration type: rangeConcentration number: 20-25Pharmaceutical form of th |
Participant Information
| Sponsor | UMC Utrecht |
|---|---|
| City | NULL |
| Country/Region | Netherlands |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | NULL |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | NULL |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |